Lexeo Therapeutics, Inc. (LXEO) Earnings
|
Expand Research on LXEO
| Next EPS Date | 12/14/26 | EPS Growth Rate | -139.4% |
|---|---|---|---|
| Average EPS % Beat Rate | +64.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
12/14/26  |
Q326 | N/A | -$0.79 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/26 |
Q226 | -$0.30 | -$0.76 | +$0.46 | N/A | N/A | N/A |  | | Details | |
| 5/11/26 |
Q126 | -$0.25 | -$0.74 | +$0.49 | N/A | N/A | N/A | | | Details | |
| 3/30/26 | Q425 | -$0.27 | -$0.86 | +$0.59 | N/A | N/A | N/A | | | Details | |
| 3/26/26 |
Q425 | N/A | -$0.86 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/25/26 |
Q425 | N/A | -$0.86 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/23/26 |
Q425 | N/A | -$0.86 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/19/26 |
Q425 | N/A | -$0.86 | N/A | N/A | N/A | N/A | N/A | N/A |
